Klaria announces last subscription date in the Companys rights issue Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that today, 6 November 2026, is the last day of…
Klaria receives additional subscription commitments and extends the subscription period in the Companys rights issue Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has received approximately SEK 2.2 million in…
Klaria has secured subscription and underwriting commitments equivalent to approximately 75.3 percent of the rights offering, as well as bridge financing of approximately SEK 30.7 million NOT FOR PUBLIC DISCLOSURE, PUBLICATION, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED…
Klaria postpones publication of the annual report Klaria Pharma Holding (publ) announces that the 2025 annual report will be published on May 29th.Due to administrative reasons, the…
Correction: Incorrect inclusion of MAR text in earlier release.Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ) Today, an extraordinary general meeting was held in Klaria Pharma Holding AB (publ), company registration number 556959-2917. Below is a…
Summary of extraordinary general meeting in Klaria Pharma Holding AB (publ) Today, an extraordinary general meeting was held in Klaria Pharma Holding AB (publ), company registration number 556959-2917. Below is a…
Klaria Pharma Holding AB (publ) Summons to Extraordinary General Meeting The shareholders of Klaria Pharma Holding AB (publ), org.nr 556959–2917, are hereby summoned to extraordinary general meeting on March 19,…